N-acetylcysteine infusion reduces the resistance index of renal artery in the early stage of systemic sclerosis. - Wikidata - wikimedia - TriplyDB

N-acetylcysteine infusion reduces the resistance index of renal artery in the early stage of systemic sclerosis.

N-acetylcysteine infusion reduces the resistance index of renal artery in the early stage of systemic sclerosis.

http://www.wikidata.org/entity/Q33555008

about

Renal disease in scleroderma: an update on evaluation, risk stratification, pathogenesis and management Renal manifestations in scleroderma: evidence for subclinical renal disease as a marker of vasculopathy.The immunological benefit of higher dose N-acetyl cysteine following mechanical ventilation in critically ill patients Is spleen circulation impaired in systemic sclerosis and what is the role of liver fibrosis?Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblasts Left Ventricular Mass and Intrarenal Arterial Stiffness as Early Diagnostic Markers in Cardiorenal Syndrome Type 5 due to Systemic Sclerosis.Increased intrarenal arterial stiffness may predict the occurrence of new digital ulcers in systemic sclerosis.Evaluation of the renal resistive index and pulsatility index in patients with pleural effusion by duplex Doppler ultrasonography.Points to consider in renal involvement in systemic sclerosis.

P2860

Q27023769-FD0F9CF4-D30D-42FA-9863-7F1F49466940 Q34106037-EDCE6AD9-3807-47CD-8700-71DE9748E408 Q34467997-81DC50C7-3414-4557-A803-28626692DA30 Q34757469-00750072-62AF-41E6-99AF-86ACB42CE3A5 Q36023711-ACC409A0-C8EE-4E37-B21C-8968F3E9472F Q36702672-5F17FCF3-ADA5-41E0-85D6-7647CF16A1E9 Q40170361-1F38055F-3F1D-41B0-84D4-075953067098 Q45136895-574B3430-1EBA-4FFC-AF73-95D86550637F Q45995241-BB4A49BC-2442-4181-9A25-5B617045581E

P2860

N-acetylcysteine infusion reduces the resistance index of renal artery in the early stage of systemic sclerosis.

http://www.wikidata.org/entity/Q33555008

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

N-acetylcysteine infusion redu ...... y stage of systemic sclerosis.

@ast

N-acetylcysteine infusion redu ...... y stage of systemic sclerosis.

@en

N-acetylcysteine infusion redu ...... y stage of systemic sclerosis.

@nl

type

label

N-acetylcysteine infusion redu ...... y stage of systemic sclerosis.

@ast

N-acetylcysteine infusion redu ...... y stage of systemic sclerosis.

@en

N-acetylcysteine infusion redu ...... y stage of systemic sclerosis.

@nl

prefLabel

N-acetylcysteine infusion redu ...... y stage of systemic sclerosis.

@ast

N-acetylcysteine infusion redu ...... y stage of systemic sclerosis.

@en

N-acetylcysteine infusion redu ...... y stage of systemic sclerosis.

@nl

P1433

Q33555008-CA8BD353-C6BE-41A9-A02A-139461BC44F8

P1476

Q33555008-9DE8AABC-121A-4831-B9DE-9597EEAA01F2

P2093

Q33555008-1B02F6FA-FE3B-4FCC-8811-85EAAF8CAD4F

Q33555008-258B7CD9-86CE-46E9-8E9B-8105C3C212D1

Q33555008-3C653C1E-C9EF-4E9D-92F6-07AB9A483272

Q33555008-416BFBC6-5E5F-4C3D-9CE5-3C1DE5B4006D

Q33555008-63B647E2-022F-4B82-8C59-653AE73D864F

Q33555008-91ECA5B2-3DE4-49C5-AEB0-BE936A308C0B

Q33555008-BA8B5A1F-41FE-4F88-9304-E548C3FAA615

Q33555008-D0087282-AE08-492E-8398-64173737A262

Q33555008-F9B68294-89D4-449A-86B6-6830478CFDB5

P2860

Q33555008-056C3AFD-E392-476E-B92B-5FC49650C745

Q33555008-0B761992-4882-441C-95DF-6411A45E3547

Q33555008-1D83AA59-9B46-4AA8-BB40-B8286AA58569

Q33555008-1FB8FBD7-9C9A-403C-8829-699433123E7A

Q33555008-2D235306-9B33-446C-9CA3-FC67518AE355

Q33555008-4B7567B2-50AA-48FC-A9D6-FC4E78BF2214

Q33555008-4DE90180-ED9F-4460-88E3-DE005EB603FB

Q33555008-4F9E4477-1070-4F2A-9961-1E9D9EF81D0B

Q33555008-5D9CFDEC-EF4A-479B-8214-541A3C26C733

Q33555008-61E6992D-27E2-41B8-910E-F9992A1CA95F

P2888

Q33555008-A74465AB-3FE2-4CB4-AFD2-4DC1F05FF0EA

P304

Q33555008-76AC69F8-EF05-4EB1-96F5-CF5B0051ED56

P31

Q33555008-306224DD-5547-4C88-BD42-0AACB52D2D8F

P356

Q33555008-0D099C79-2ED4-480B-966B-3F30A9FF720E

P433

Q33555008-CA55A637-70DB-4E7F-81A2-B3389C7D08A4

P478

Q33555008-8FAAF0B7-1E8D-4F46-9480-025E6AFEA022

P50

Q33555008-4CC1E709-3C41-43E8-94A1-3A6C95F68BC2

P577

Q33555008-8FAD95A8-7A73-44DE-A8CE-473F0767F489

P5875

Q33555008-78C292A6-2A8E-4801-932A-4DC3C64B8505

P6179

Q33555008-8CEAFCFD-8A9F-4CC1-841E-7117586F39FE

P698

Q33555008-1413107F-51D3-42C4-9BA4-D9F13102AD53

P932

Q33555008-9705FAAE-4AB0-4ADB-AF73-747138FAFA54

P356

P1433

Acta Pharmacologica Sinica

P1476

N-acetylcysteine infusion redu ...... y stage of systemic sclerosis.

@en

P2093

Antonietta Gigante

http://www.w3.org/2001/XMLSchema#string

Antonio Amoroso

http://www.w3.org/2001/XMLSchema#string

Biagio Barbano

http://www.w3.org/2001/XMLSchema#string

Carmelina Rossi

http://www.w3.org/2001/XMLSchema#string

Enrico M Zardi

http://www.w3.org/2001/XMLSchema#string

Felice Salsano

http://www.w3.org/2001/XMLSchema#string

Ginevra Menghi

http://www.w3.org/2001/XMLSchema#string

Rosario Cianci

http://www.w3.org/2001/XMLSchema#string

Simonetta Pisarri

http://www.w3.org/2001/XMLSchema#string

P2860

Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis

Fluid shear stress induction of the tissue factor promoter in vitro and in vivo is mediated by Egr-1

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

N-acetylcysteine ameliorates renal microcirculation: studies in rats.

Significant changes of peripheral perfusion and plasma adrenomedullin levels in N-acetylcysteine long term treatment of patients with sclerodermic Raynauds phenomenon.

Duplex Doppler evaluation of native kidney dysfunction: obstructive and nonobstructive disease.

European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes.

N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.

Renal vascular histology and morphometry in systemic sclerosis. A case-control autopsy study.

Renal manifestations of systemic sclerosis--clinical features and outcome assessment.

P2888

P304

1283-1288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/APS.2009.128

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26789570

http://www.w3.org/2001/XMLSchema#string

P6179

1003417452

http://www.w3.org/2001/XMLSchema#string

P698

19730428

http://www.w3.org/2001/XMLSchema#string

P932

4007187

http://www.w3.org/2001/XMLSchema#string